Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Ask a
question
Favorite
siRNA targeting MALAT1 (si-MALAT1#1 and si-MALAT1 #2), siRNA negative control (si-NC), pcDNA, and E2F5 were bought from Genepharma (Shanghai, China). miR-1271-5p mimics (miR-1271-5p) and miR-NC, and miR-1271-5p inhibitor (anti-miR-1271-5p) and anti-miR-NC were purchased from RIBOBIO (Guangzhou, China). Cell transfection was performed using Lipofectamine 3000 (Invitrogen).
Copyright and License information: ©2020 Wang et al.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
